2-(4-(2-hydroxypropan-2-yl)phenyl)-6-(3-methyloxetan-3-yl)-4-(2-(2,2,2-trifluoroethoxy)phenyl)-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-one

ID: ALA5181454

Chembl Id: CHEMBL5181454

PubChem CID: 163405483

Max Phase: Preclinical

Molecular Formula: C28H27F3N2O4

Molecular Weight: 512.53

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(O)c1ccc(N2Cc3c(cc(C4(C)COC4)nc3-c3ccccc3OCC(F)(F)F)C2=O)cc1

Standard InChI:  InChI=1S/C28H27F3N2O4/c1-26(2,35)17-8-10-18(11-9-17)33-13-21-20(25(33)34)12-23(27(3)14-36-15-27)32-24(21)19-6-4-5-7-22(19)37-16-28(29,30)31/h4-12,35H,13-16H2,1-3H3

Standard InChI Key:  XJGOWQKCDBZTCD-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5181454

    ---

Associated Targets(Human)

UGCG Tclin Ceramide glucosyltransferase (308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ugcg Ceramide glucosyltransferase (150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 512.53Molecular Weight (Monoisotopic): 512.1923AlogP: 5.37#Rotatable Bonds: 6
Polar Surface Area: 71.89Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.84CX Basic pKa: 0.21CX LogP: 4.75CX LogD: 4.75
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.48Np Likeness Score: -0.50

References

1. Wang J, Reynolds M, Ibáñez I, Sasaki Y, Tanaka Y, Kikuchi F, Ohashi T, Sato S, Miyabayashi M, Fujii T, Tanaka Y..  (2022)  Photoredox-based late-stage functionalization in SAR study for in vivo potent glucosylceramide synthase inhibitor.,  77  [PMID:36341811] [10.1016/j.bmcl.2022.129039]

Source